Mar. Drugs 2009, 7(4), 754-786; doi:10.3390/md7040754
Review

Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition

Laboratoire de Synthèse et Physicochimie de Molécules d’Intérêt Biologique, UMR CNRS 5068, Université Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cédex 9, France
* Author to whom correspondence should be addressed.
Received: 30 October 2009; in revised form: 18 November 2009 / Accepted: 27 November 2009 / Published: 1 December 2009
(This article belongs to the Special Issue Alkaloid Analogs)
PDF Full-text Download PDF Full-Text [955 KB, uploaded 1 December 2009 09:49 CET]
Abstract: Granulatimide and isogranulatimide are alkaloids obtained from marine sources which have been shown to inhibit cell-cycle G2-checkpoint, targeting more particularly checkpoint 1 kinase (Chk1). At a structural level, they possess a characteristic pyrrolocarbazole framework also shared by the well-known rebeccamycin and staurosporine microbial metabolites which have been described to inhibit topoisomerase I and diverse kinases, respectively. This review reports precisely on the synthesis and kinase inhibitory activities of pyrrolocarbazole-based analogues of granulatimide.
Keywords: granulatimide; isogranulatimide; pyrrolocarbazole; indolocarbazole; kinase inhibitor

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Deslandes, S.; Chassaing, S.; Delfourne, E. Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition. Mar. Drugs 2009, 7, 754-786.

AMA Style

Deslandes S, Chassaing S, Delfourne E. Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition. Marine Drugs. 2009; 7(4):754-786.

Chicago/Turabian Style

Deslandes, Sébastien; Chassaing, Stefan; Delfourne, Evelyne. 2009. "Marine Pyrrolocarbazoles and Analogues: Synthesis and Kinase Inhibition." Mar. Drugs 7, no. 4: 754-786.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert